story of the week
Gut Microbiome Influences Efficacy of PD-1–Based Immunotherapy Against Epithelial Tumors
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Science (New York, N.Y.)
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Gut Microbiome Influences Efficacy of PD-1-Based Immunotherapy Against Epithelial Tumors
Science 2017 Nov 02;[EPub Ahead of Print], B Routy, E Le Chatelier, L Derosa, CPM Duong, MT Alou, R Daillère, A Fluckiger, M Messaoudene, C Rauber, MP Roberti, M Fidelle, C Flament, V Poirier-Colame, P Opolon, C Klein, K Iribarren, L Mondragón, N Jacquelot, B Qu, G Ferrere, C Clémenson, L Mezquita, JR Masip, C Naltet, S Brosseau, C Kaderbhai, C Richard, H Rizvi, F Levenez, N Galleron, B Quinquis, N Pons, B Ryffel, V Minard-Colin, P Gonin, JC Soria, E Deutsch, Y Loriot, F Ghiringhelli, G Zalcman, F Goldwasser, B Escudier, MD Hellmann, A Eggermont, D Raoult, L Albiges, G Kroemer, L ZitvogelFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.